Next Article in Journal
Pulmonary Infection Caused by Mycobacterium malmoense in a Chronic HIV-Infected Individual Participating in a Therapeutic Vaccine Trial
Previous Article in Journal
The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 9
Issue 10
10.3390/vaccines9101102
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review

by
Meng Lv
1,2,3,†,
Xufei Luo
4,†,
Quan Shen
2,3,5,
Ruobing Lei
2,3,5,
Xiao Liu
4,
Enmei Liu
2,3,6,
Qiu Li
1,2,3,* and
Yaolong Chen
7,8,9,10,11,12,*
1
Department of Nephrology, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China
2
National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China
3
Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
4
School of Public Health, Lanzhou University, Lanzhou 730000, China
5
Chevidence Lab Child & Adolescent Health, Department of Pediatric Research Institute, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China
6
Department of Respiratory Medicine, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China
7
Institute of Health Data Science, Lanzhou University, Lanzhou 730000, China
8
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China
9
WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou 730000, China
10
Guideline International Network Asia, Lanzhou 730000, China
11
Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou University, Lanzhou 730000, China
12
Lanzhou University GRADE Center, Lanzhou 730000, China
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Vaccines 2021, 9(10), 1102; https://doi.org/10.3390/vaccines9101102
Submission received: 1 August 2021 / Revised: 20 September 2021 / Accepted: 24 September 2021 / Published: 29 September 2021
Browse Figures
Review Reports Versions Notes

Abstract

Aim: To identify the safety, immunogenicity, and protective efficacy of COVID-19 vaccines in children and adolescents. Methods: We conducted a systematic review of published studies and ongoing clinical studies related to the safety, immunogenicity, and efficacy of COVID-19 vaccine in children or adolescents (aged < 18 years). Databases including PubMed, Web of Science, WHO COVID-19 database, and China National Knowledge Infrastructure (CNKI) were searched on 23 July 2021. International Clinical Trials Registry Platform (ICTRP) was also searched to identify ongoing studies. Results: Eight published studies with a total of 2852 children and adolescents and 28 ongoing clinical studies were included. Of the eight published studies, two were RCTs, two case series, and four case reports. The investigated COVID-19 vaccines had good safety profiles in children and adolescents. Injection site pain, fatigue, headache, and chest pain were the most common adverse events. A limited number of cases of myocarditis and pericarditis were reported. The RCTs showed that the immune response to BNT162b2 in adolescents aged 12–15 years was non-inferior to that in young people aged 16–25 years, while with 3 μg CoronaVac injection the immune response was stronger than with 1.5 μg. The efficacy of BNT162b2 was 100% (95% CI: 75.3 to 100), based on one RCT. Of the 28 ongoing clinical studies, twenty-three were interventional studies. The interventional studies were being conducted in fifteen countries, among them, China (10, 43.5%) and United States(9, 39.1%) had the highest number of ongoing trials. BNT162b2 was the most commonly studied vaccine in the ongoing trials. Conclusion: Two COVID-19 vaccines have potential protective effects in children and adolescents, but awareness is needed to monitor possible adverse effects after injection. Clinical studies of the COVID-19 vaccination in children and adolescents with longer follow-up time, larger sample size, and a greater variety of vaccines are still urgently needed.
Keywords: COVID-19; vaccine; children; adolescents; systematic review COVID-19; vaccine; children; adolescents; systematic review

Share and Cite

MDPI and ACS Style

Lv, M.; Luo, X.; Shen, Q.; Lei, R.; Liu, X.; Liu, E.; Li, Q.; Chen, Y. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review. Vaccines 2021, 9, 1102. https://doi.org/10.3390/vaccines9101102

AMA Style

Lv M, Luo X, Shen Q, Lei R, Liu X, Liu E, Li Q, Chen Y. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review. Vaccines. 2021; 9(10):1102. https://doi.org/10.3390/vaccines9101102

Chicago/Turabian Style

Lv, Meng, Xufei Luo, Quan Shen, Ruobing Lei, Xiao Liu, Enmei Liu, Qiu Li, and Yaolong Chen. 2021. "Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review" Vaccines 9, no. 10: 1102. https://doi.org/10.3390/vaccines9101102

APA Style

Lv, M., Luo, X., Shen, Q., Lei, R., Liu, X., Liu, E., Li, Q., & Chen, Y. (2021). Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review. Vaccines, 9(10), 1102. https://doi.org/10.3390/vaccines9101102

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop